FormWeb • osimertinib

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

osimertinib

osimertinib

Non-formulary Anti-Neoplastic Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Tagrisso	TABLET, ORAL	40 mg, 80 mg

Comments:

Oral Chemotherapy Drug Pharmacist Education

Oral Chemotherapy TOC Information

Tagrisso -- Available to hospital only through specialty pharmacy program. Rare use expected and expensive. Inpatient should use own supply. Defer initiation until after discharge.

Reviewed: 23 February 2016 (Tagrisso)

Last updated: Apr. 11, 2024

HAZ-MED: Group 1
Chemotherapy:

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.